Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults

Volume 20, Issue 1, December 2024 .

Source: Human Vaccines and Immunotherapeutics - March 21, 2024 Category: Allergy & Immunology Authors: Prasad S. KulkarniChandrasekaran PadmapriyadarsiniJohan VekemansAshish BavdekarMadhu GuptaPraveen KulkarniB.S. GargNithya J. GogtayMuralidhar TambeSanjay LalwaniKiranjit SinghRenuka MunshiSushant MeshramT.S. SelvavinayagamKrishna PandeyDevi Madhavi Bhimar Source Type: research